These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 27198515)
1. Brefeldin A reduces tumor necrosis factor-α-stimulated production of inflammatory mediators by suppressing the Akt, mTOR, and NF-κB pathways in human keratinocytes. Nam YJ; Lee CS Naunyn Schmiedebergs Arch Pharmacol; 2016 Sep; 389(9):951-60. PubMed ID: 27198515 [TBL] [Abstract][Full Text] [Related]
2. Flavonoid myricetin inhibits TNF-α-stimulated production of inflammatory mediators by suppressing the Akt, mTOR and NF-κB pathways in human keratinocytes. Lee da H; Lee CS Eur J Pharmacol; 2016 Aug; 784():164-72. PubMed ID: 27221774 [TBL] [Abstract][Full Text] [Related]
3. Apocynin inhibits Toll-like receptor-4-mediated activation of NF-κB by suppressing the Akt and mTOR pathways. Nam YJ; Kim A; Sohn DS; Lee CS Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1267-1277. PubMed ID: 27590200 [TBL] [Abstract][Full Text] [Related]
4. 3,4,5-Tricaffeoylquinic acid inhibits tumor necrosis factor-α-stimulated production of inflammatory mediators in keratinocytes via suppression of Akt- and NF-κB-pathways. Lee CS; Lee SA; Kim YJ; Seo SJ; Lee MW Int Immunopharmacol; 2011 Nov; 11(11):1715-23. PubMed ID: 21704193 [TBL] [Abstract][Full Text] [Related]
5. Rotundarpene inhibits TNF-α-induced activation of the Akt, mTOR, and NF-κB pathways, and the JNK and p38 associated with production of reactive oxygen species. Kim A; Nam YJ; Shin YK; Lee MS; Sohn DS; Lee CS Mol Cell Biochem; 2017 Oct; 434(1-2):113-125. PubMed ID: 28432555 [TBL] [Abstract][Full Text] [Related]
6. Sesquiterpene lactone parthenolide attenuates production of inflammatory mediators by suppressing the Toll-like receptor-4-mediated activation of the Akt, mTOR, and NF-κB pathways. Nam YJ; Lee DH; Lee MS; Lee CS Naunyn Schmiedebergs Arch Pharmacol; 2015 Sep; 388(9):921-30. PubMed ID: 25971793 [TBL] [Abstract][Full Text] [Related]
7. Apigenin reduces the Toll-like receptor-4-dependent activation of NF-κB by suppressing the Akt, mTOR, JNK, and p38-MAPK. Kim A; Lee CS Naunyn Schmiedebergs Arch Pharmacol; 2018 Mar; 391(3):271-283. PubMed ID: 29264665 [TBL] [Abstract][Full Text] [Related]
8. K Jeong Nam Y; Kim A; Sung Lee M; Suep Sohn D; Soo Lee C Eur J Pharmacol; 2017 Nov; 815():190-201. PubMed ID: 28923349 [TBL] [Abstract][Full Text] [Related]
9. Quercetin-3-O-(2″-galloyl)-α-l-rhamnopyranoside inhibits TNF-α-activated NF-κB-induced inflammatory mediator production by suppressing ERK activation. Lee CS; Jeong EB; Kim YJ; Lee MS; Seo SJ; Park KH; Lee MW Int Immunopharmacol; 2013 Aug; 16(4):481-7. PubMed ID: 23684917 [TBL] [Abstract][Full Text] [Related]
10. Rotundarpene inhibits toll-like receptor 2 activation-induced production of inflammatory mediators in keratinocytes by suppressing the Akt and NF-κB pathways. Kim YJ; Jung EB; Lee MS; Seo SJ; Kim MH; Lee MW; Lee CS Int Immunopharmacol; 2014 Feb; 18(2):325-32. PubMed ID: 24378401 [TBL] [Abstract][Full Text] [Related]
11. Protection by mTOR Inhibition on Zymosan-Induced Systemic Inflammatory Response and Oxidative/Nitrosative Stress: Contribution of mTOR/MEK1/ERK1/2/IKKβ/IκB-α/NF-κB Signalling Pathway. Sahan-Firat S; Temiz-Resitoglu M; Guden DS; Kucukkavruk SP; Tunctan B; Sari AN; Kocak Z; Malik KU Inflammation; 2018 Feb; 41(1):276-298. PubMed ID: 29110153 [TBL] [Abstract][Full Text] [Related]
12. Protocatechuic acid inhibits Toll-like receptor-4-dependent activation of NF-κB by suppressing activation of the Akt, mTOR, JNK and p38-MAPK. Nam YJ; Lee CS Int Immunopharmacol; 2018 Feb; 55():272-281. PubMed ID: 29291542 [TBL] [Abstract][Full Text] [Related]
13. Impaired PI3K/Akt activation-mediated NF-kappaB inactivation under elevated TNF-alpha is more vulnerable to apoptosis in vitiliginous keratinocytes. Kim NH; Jeon S; Lee HJ; Lee AY J Invest Dermatol; 2007 Nov; 127(11):2612-7. PubMed ID: 17522703 [TBL] [Abstract][Full Text] [Related]
14. Diarylheptanoid hirsutenone prevents tumor necrosis factor-alpha-stimulated production of inflammatory mediators in human keratinocytes through NF-kappaB inhibition. Lee CS; Ko HH; Seo SJ; Choi YW; Lee MW; Myung SC; Bang H Int Immunopharmacol; 2009 Aug; 9(9):1097-104. PubMed ID: 19464389 [TBL] [Abstract][Full Text] [Related]
15. Caffeine suppresses lipopolysaccharide-stimulated BV2 microglial cells by suppressing Akt-mediated NF-κB activation and ERK phosphorylation. Kang CH; Jayasooriya RG; Dilshara MG; Choi YH; Jeong YK; Kim ND; Kim GY Food Chem Toxicol; 2012 Dec; 50(12):4270-6. PubMed ID: 22974838 [TBL] [Abstract][Full Text] [Related]
16. TNF-alpha stimulates Akt by a distinct aPKC-dependent pathway in premalignant keratinocytes. Faurschou A; Gniadecki R Exp Dermatol; 2008 Dec; 17(12):992-7. PubMed ID: 18557926 [TBL] [Abstract][Full Text] [Related]
17. Bidirectional regulation of nuclear factor-κB and mammalian target of rapamycin signaling functionally links Bnip3 gene repression and cell survival of ventricular myocytes. Dhingra R; Gang H; Wang Y; Biala AK; Aviv Y; Margulets V; Tee A; Kirshenbaum LA Circ Heart Fail; 2013 Mar; 6(2):335-43. PubMed ID: 23395931 [TBL] [Abstract][Full Text] [Related]
18. Pinocembrin inhibits lipopolysaccharide-induced inflammatory mediators production in BV2 microglial cells through suppression of PI3K/Akt/NF-κB pathway. Zhou LT; Wang KJ; Li L; Li H; Geng M Eur J Pharmacol; 2015 Aug; 761():211-6. PubMed ID: 26049009 [TBL] [Abstract][Full Text] [Related]
19. Anti-proliferative effect of RCE-4 from Reineckia carnea on human cervical cancer HeLa cells by inhibiting the PI3K/Akt/mTOR signaling pathway and NF-κB activation. Bai C; Yang X; Zou K; He H; Wang J; Qin H; Yu X; Liu C; Zheng J; Cheng F; Chen J Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):573-84. PubMed ID: 26935715 [TBL] [Abstract][Full Text] [Related]
20. 3,4,5-tricaffeoylquinic Acid inhibits the lipopolysaccharide-stimulated production of inflammatory mediators in keratinocytes. Lee SA; Jung EB; Lee SH; Kim YJ; Bang H; Seo SJ; Choi YW; Kim MH; Lee MW; Lee CS Pharmacology; 2012; 90(3-4):183-92. PubMed ID: 22947851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]